Latest market price
39.04
-0.66-1.66%
LBRXQT87LB Pharmaceuticals Inc Common Stock·NASDAQ
39.04-1.66%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 13, 20264Statement of changes in beneficial ownership
Oct 13, 20264Statement of changes in beneficial ownership
Oct 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 05, 2026EFFECTNotice of effectiveness
Oct 01, 2026S-3ASRS-3ASR
Oct 01, 2026POS AMPost-effective amendment
Sep 24, 20263Initial statement of beneficial ownership
Sep 15, 20268-KCurrent report
Sep 15, 2026424B3Prospectus
Sep 14, 20263Initial statement of beneficial ownership
Sep 03, 20268-KCurrent report
Sep 03, 2026424B3Prospectus
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Aug 11, 2026424B3Prospectus
Aug 03, 20264Statement of changes in beneficial ownership
Jul 29, 20268-KCurrent report
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 29, 2026424B3Prospectus
Jul 22, 2026424B3Prospectus
Jul 22, 20268-KCurrent report
Jul 16, 2026SC 13GBeneficial ownership statement (passive)
Jun 10, 20268-KCurrent report
Jun 10, 2026424B3Prospectus